Vitamin E forms inhibit IL-13/STAT6-induced eotaxin-3 secretion by up-regulation of PAR4, an endogenous inhibitor of atypical PKC in human lung epithelial cells.
Yun Wang, Michelle Moreland, James G Wagner, Bruce N Ames, Beate Illek, David B Peden, Qing Jiang
Index: J. Nutr. Biochem. 23(6) , 602-8, (2011)
Full Text: HTML
Abstract
Eotaxin-3 (CCL-26), a potent chemokine for eosinophil recruitment and contributing significantly to the pathogenesis of asthma, is secreted by lung epithelial cells in response to T helper 2 cytokines including interleukin 13 (IL-13). Here we showed that vitamin E forms, but not their metabolites, differentially inhibited IL-13-stimulated generation of eotaxin-3 in human lung epithelial A549 cells. The relative inhibitory potency was γ-tocotrienol (γ-TE) (IC50 ~15 μM)>γ-tocopherol, δ-tocopherol (IC50 ~25-50 μM)>α-tocopherol. Consistent with suppression of eotaxin, γ-TE treatment impaired IL-13-induced phosphorylation of STAT6, the key transcription factor for activation of eotaxin expression, and consequently blocked IL-13-stimulated DNA-binding activity of STAT6. In search of the upstream target of γTE by using inhibitor and siRNA approaches, we discovered that the atypical protein kinase C (aPKC) signaling, instead of classical PKC, p38 MAPK, JNK or ERK, played a critical role in IL-13-stimulated eotaxin generation and STAT6 activation. While showing no obvious effect on aPKC expression or phosphorylation, γ-TE treatment resulted in increased expression of prostate-apoptosis-response 4 (PAR4), an endogenous negative regulator of aPKCs. Importantly, γ-TE treatment led to enhanced formation of aPKC/PAR4 complex that is known to reduce aPKC activity via protein-protein crosstalk. Our study demonstrated that γ-TE inhibited IL-13/STAT6-activated eotaxin secretion via up-regulation of PAR4 expression and enhancement of aPKC-PAR4 complex formation. These results support the notion that specific vitamin E forms may be useful anti-asthmatic agents.Copyright © 2012 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
2015-03-01
[Pharm. Dev. Technol. 20(2) , 169-75, (2015)]
Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.
2014-09-01
[Acta. Pharm. 64(3) , 299-309, (2014)]
Coffee silverskin: a possible valuable cosmetic ingredient.
2015-03-01
[Pharm. Biol. 53(3) , 386-94, (2015)]
2015-06-01
[J. Anim. Sci. 93 , 3018-33, (2015)]
2015-09-18
[J. Chromatogr. A. 1412 , 59-66, (2015)]